Skip to main content
. 2023 Jul 8;9(2):vead044. doi: 10.1093/ve/vead044

Figure 5.

Figure 5.

cVDPV2 outbreak risk. cVDPV2 emergence after an mOPV2 vaccination campaign (A–C) or importation of a single infant immunized with Sabin 2 (D–F) occurring up to 5 years of vaccination cessation with fecal–oral doses equivalent to Matlab (4.0e-7 grams per contact, A/D), five times greater (2.0e-6 grams per contact, B/E), and ten times greater (4.0e-6 grams per contact, C/F) than that inferred for Matlab during an mOPV2 clinical trial. Each cell in the heatmap represents results from 800 simulation runs.